Breaking: AstraZeneca Vaccine Safe, 79 Percent Effective in U.S. Trial

AstraZeneca's COVID-19 vaccine was 79 percent effective in preventing symptomatic disease and 100 percent effective against severe disease and hospitalization in a new U.S.-based clinical trial, the company announced on Monday. 

Experts did not find any safety concerns related to the vaccine, including any increased risk of rare blood clots that have raised concern in Europe.

AstraZeneca Vaccine Safe, 79 Percent Effective in U.S. Trial Experts did not find any safety concerns related to the vaccine, including any increased risk of rare blood clots ... READ MORE ADVERTISEMENT Follow Us & Share 19 West 44th Street, Suite 1701, New York, NY, 10036, USA Your Preferences | Unsubscribe | Privacy View this e-mail in your browser.